Pages that link to "Q43814414"

The following pages link to Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma (Q43814414):

Displaying 37 items.

• Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers (Q21134689) (← links)
• Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis (Q24598655) (← links)
• Genetic abnormalities in pancreatic cancer (Q24800194) (← links)
• Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma (Q30491042) (← links)
• Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects (Q33801377) (← links)
• Precursor lesions of pancreatic cancer (Q33855814) (← links)
• Molecular Signatures of Pancreatic Cancer (Q33918801) (← links)
• A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps (Q34293192) (← links)
• Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer (Q34449043) (← links)
• K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking (Q34596601) (← links)
• Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments (Q35093755) (← links)
• Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies (Q35626572) (← links)
• Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma (Q35748110) (← links)
• Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis (Q35792134) (← links)
• Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases (Q36108445) (← links)
• Advances in biomarker research for pancreatic cancer (Q36126609) (← links)
• Molecular biology of exocrine pancreatic cancer. (Q36499575) (← links)
• Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines (Q36614480) (← links)
• Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms (Q36670990) (← links)
• Epigenetics and epigenetic alterations in pancreatic cancer. (Q37041763) (← links)
• Genetic and epigenetic alterations of familial pancreatic cancers (Q37148201) (← links)
• MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. (Q37692456) (← links)
• Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK. (Q38722321) (← links)
• Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma. (Q39372582) (← links)
• Aberrant Methylation of RASSF2A in Human Pancreatic Ductal Adenocarcinoma and Its Relation to Clinicopathologic Features (Q39500433) (← links)
• The promise of epigenomic therapeutics in pancreatic cancer (Q41473804) (← links)
• CpG island methylation profile of pancreatic intraepithelial neoplasia (Q42053166) (← links)
• Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective (Q42115029) (← links)
• Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma (Q47162128) (← links)
• Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms (Q47615275) (← links)
• Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens (Q51488757) (← links)
• Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. (Q53372663) (← links)
• Epigenetic changes in the DAP‐kinase CpG island in pediatric lymphoma (Q54745616) (← links)
• Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma (Q80307226) (← links)
• Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients (Q90134057) (← links)
• Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B-cell lymphoma with central nervous system involvement: A novel approach to diagnosis (Q92136660) (← links)
• Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis (Q93157538) (← links)